Literature DB >> 24007642

Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance.

Jessica L Dennison1, Jim Stack, Stephen Beatty, John M Nolan.   

Abstract

This study compares in vivo measurements of macular pigment (MP) obtained using customized heterochromatic flicker photometry (cHFP; Macular Metrics Densitometer(™)), dual-wavelength fundus autofluorescence (Heidelberg Spectralis(®) HRA + OCT MultiColor) and single-wavelength fundus reflectance (Zeiss Visucam(®) 200). MP was measured in one eye of 62 subjects on each device. Data from 49 subjects (79%) was suitable for analysis. Agreement between the Densitometer and Spectralis was investigated at various eccentricities using a variety of quantitative and graphical methods, including: Pearson correlation coefficient to measure degree of scatter (precision), accuracy coefficient, concordance correlation coefficient (ccc), paired t-test, scatter and Bland-Altman plots. The relationship between max MP from the Visucam and central MP from the Spectralis and Densitometer was investigated using regression methods. Agreement was strong between the Densitometer and Spectralis at all central eccentricities (e.g. at 0.25° eccentricity: accuracy = 0.97, precision = 0.90, ccc = 0.87). Regression analysis showed a very weak relationship between the Visucam and Densitometer (e.g. Visucam max on Densitometer central MP: R(2) = 0.008, p = 0.843). Regression analysis also demonstrated a weak relationship between MP measured by the Spectralis and Visucam (e.g. Visucam max on Spectralis central MP: R(2) = 0.047, p = 0.348). MP values obtained using the Heidelberg Spectralis are comparable to MP values obtained using the Densitometer. In contrast, MP values obtained using the Zeiss Visucam are not comparable with either the Densitometer or the Spectralis MP measuring devices. Taking cHFP as the current standard to which other MP measuring devices should be compared, the Spectralis is suitable for use in a clinical and research setting, whereas the Visucam is not.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  customized heterochromatic flicker photometry; fundus autofluorescence; fundus reflectance; macular pigment

Mesh:

Substances:

Year:  2013        PMID: 24007642     DOI: 10.1016/j.exer.2013.08.014

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  24 in total

1.  Reliability of a commercially available heterochromatic flicker photometer, the MPS2, for measuring the macular pigment optical density of a Japanese population.

Authors:  Akira Obana; Yuko Gohto; Takatoshi Moriyama; Takahiko Seto; Hiroyuki Sasano; Shigetoshi Okazaki
Journal:  Jpn J Ophthalmol       Date:  2018-03-28       Impact factor: 2.447

Review 2.  What do we know about the macular pigment in AMD: the past, the present, and the future.

Authors:  Ranganathan Arunkumar; Charles M Calvo; Christopher D Conrady; Paul S Bernstein
Journal:  Eye (Lond)       Date:  2018-03-26       Impact factor: 3.775

3.  Comment on Richer et al. Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults. Nutrients 2021, 13, 3191.

Authors:  Marina Green-Gomez; Warren Roche; John M Nolan
Journal:  Nutrients       Date:  2022-07-05       Impact factor: 6.706

4.  REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING.

Authors:  Qi Sheng You; Dirk-Uwe G Bartsch; Mark Espina; Mostafa Alam; Natalia Camacho; Nadia Mendoza; William R Freeman
Journal:  Retina       Date:  2016-07       Impact factor: 4.256

Review 5.  Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.

Authors:  Paul S Bernstein; Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Rajalekshmy Shyam; Bradley S Henriksen; John M Nolan
Journal:  Prog Retin Eye Res       Date:  2015-11-02       Impact factor: 21.198

6.  Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.

Authors:  Kimberly J Cocce; Sandra S Stinnett; Ulrich F O Luhmann; Lejla Vajzovic; Anupama Horne; Stefanie G Schuman; Cynthia A Toth; Scott W Cousins; Eleonora M Lad
Journal:  Am J Ophthalmol       Date:  2018-03-15       Impact factor: 5.258

7.  Measuring Visual Function Using the MultiQuity System: Comparison with an Established Device.

Authors:  Patrycja Smolarek-Kasprzak; John M Nolan; Stephen Beatty; Jessica Dennison; Kwadwo Owusu Akuffo; Robert Kuchling; Jim Stack; Graham O'Regan
Journal:  J Ophthalmol       Date:  2014-12-16       Impact factor: 1.909

8.  Standardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique.

Authors:  Marina Green-Gomez; Paul S Bernstein; Christine A Curcio; Rachel Moran; Warren Roche; John M Nolan
Journal:  Transl Vis Sci Technol       Date:  2019-12-18       Impact factor: 3.283

Review 9.  Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence.

Authors:  Drake W Lem; Dennis L Gierhart; Pinakin Gunvant Davey
Journal:  Nutrients       Date:  2021-06-06       Impact factor: 5.717

Review 10.  The Photobiology of Lutein and Zeaxanthin in the Eye.

Authors:  Joan E Roberts; Jessica Dennison
Journal:  J Ophthalmol       Date:  2015-12-20       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.